Column Group IV-A, LP's Net Worth
$0
Estimate Recalculated Sep 8, 2024 07:31PM EST
Who is Column Group IV-A, LP?
Column Group IV-A, LP does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include NGM BIOPHARMACEUTICALS INC, and RAPT Therapeutics, Inc..
SEC CIK
Column Group IV-A, LP's CIK is 0001796353
Past Insider Trading and Trends
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
NGM BIOPHARMACEUTICALS INC (NGM) No price found
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -21.74M |
—
|
—
| 1K |
Apr 5
| |||
Form 4
| +2.44% | 22.63K |
$0.69 | $15,506.86 | 949.86K |
Nov 15 - Nov 16
| |||
Form 4
| +24.80% | 184.27K |
$5.00 | $921,109.56 | 927.23K |
Jan 30 - Jan 31
| |||
Form 4
| +1.35% | 9.9K |
$5.00 | $49,494.06 | 742.96K |
Jan 23
| |||
Form 4
| +5.49% | 38.14K |
$5.00 | $190,602.67 | 733.06K |
Jan 19 - Jan 20
| |||
Form 4
| +0.78% | 5.38K |
$4.95 | $26,602.81 | 694.92K |
Jan 12
| |||
Form 4
| +81.23% | 309.07K |
$4.79 | $1,479,358.93 | 689.54K |
Jan 10 - Jan 11
| |||
Form 4
| +0.08% | 300 |
$4.98 | $1,493.01 | 380.47K |
Dec 12
| |||
Form 4
| +11.87% | 40.33K |
$5.00 | $201,587.91 | 380.17K |
Nov 21 - Nov 22
| |||
Form 4
| +69.33% | 139.15K |
$4.92 | $684,426.74 | 339.85K |
Nov 3 - Nov 4
| |||
Form 4
| +62.09% | 76.88K |
$4.86 | $373,637.60 | 200.7K |
Oct 27
| |||
Form 4
|
∞
| 123.82K |
$4.81 | $595,428.06 | 123.82K |
Oct 25 - Oct 26
| |||
Form 4
| +56.03% | 984.16K |
$13.50 | $13,286,173.50 | 2.74M |
Jun 9
| |||
Form 4
| +1.99% | 34.2K |
$13.03 | $445,738.86 | 1.76M |
Jun 2
| |||
Form 4
| +4.81% | 153.81K |
$13.46 | $2,069,667.23 | 3.35M |
May 31 - Jun 1
| |||
Form 4
| +0.74% | 22.91K |
$13.47 | $309,035.22 | 3.13M |
May 26 - May 27
| |||
Form 4
| +2.05% | 61.12K |
$13.40 | $819,948.39 | 3.05M |
May 24 - May 25
| |||
Form 4
| +1.36% | 39.7K |
$13.37 | $530,454.27 | 2.95M |
May 19 - May 20
| |||
Form 4
| +5.67% | 151.7K |
$13.31 | $2,022,003.67 | 2.83M |
May 17 - May 18
| |||
Form 4
| +6.80% | 162.53K |
$12.90 | $427,891.15 | 2.55M |
May 13 - May 16
| |||
Form 4
| +3.97% | 166.35K |
$11.63 | $1,902,031.79 | 4.35M |
May 11 - May 12
| |||
Form 4
| +6.42% | 114.44K |
$11.08 | $1,252,982.42 | 1.9M |
May 9 - May 10
| |||
Form 4
| +339.88% | 849.7K |
—
|
—
| 1.1M |
Jan 24 - Jan 25
| |||
| No matching records found | |||||||||
RAPT Therapeutics, Inc. (RAPT) Snapshot price: $1.83
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +0.15% | 1.9K |
$12.45 | $23,664.31 | 1.28M |
May 25
| |||
Form 4
| +1.06% | 26.55K |
$12.25 | $323,745.09 | 2.54M |
May 23 - May 24
| |||
Form 4
|
∞
| 1.25M |
$10.67 | $13,339,375.01 | 1.25M |
May 10
| |||
| No matching records found | |||||||||